EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Cho Bi (001550) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Cho Bi KRW 8,154, price KRW 10,470, upside -22.1%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Basic Materials · KR · ISIN KR7001550003

CB Some data Sep 24, 2026

Cho Bi

001550 · KO

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value 8,154 KRW · Overvalued (−22%)
!Quality 52/100
!Weak Growth (revenue 5y +6.3 %/yr)
!Thin margins · 0.1% net margin (TTM)
✓Low debt · generates free cash flow
!Trails peers (3/9)
!Narrow moat 19/100
!Evidence only medium, so the estimate is less certain
!Weak on valuation: 4 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

33,250 KRW 9,210 KRW Fair Value 8,154 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 9,210 KRW – 33,250 KRW · fair‑value band 7,074 KRW – 9,102 KRW · the 10,470 KRW price screens above the 8,154 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Cho Bi in your weekly email

Every Wednesday you see whether Cho Bi is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Chobi Company Limited produces and distributes composite fertilizers in South Korea. It offers hydrophonic fertilizers, controlled release fertilizers, MCF organic fertilizers, and PNS CRF fertilizers. The company was formerly known as Chosun Fertilizer Industry Co., Ltd. and changed its name to Chobi Company Limited in October 1990.

Show more

Chobi Company Limited produces and distributes composite fertilizers in South Korea. It offers hydrophonic fertilizers, controlled release fertilizers, MCF organic fertilizers, and PNS CRF fertilizers. The company was formerly known as Chosun Fertilizer Industry Co., Ltd. and changed its name to Chobi Company Limited in October 1990. Chobi Company Limited was founded in 1955 and is headquartered in Seoul, South Korea. Chobi Company Limited is a subsidiary of Kyung Nong Corporation.

Stock analysis

Cho Bi (001550) currently trades at 10,470 KRW, while our model-based Fair Value estimate is 8,154 KRW, implying the stock looks roughly 28.4% overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 9,529 KRW per share, and 3 of the 23 models we run sit above the 10,470 KRW price.

Bear case: the Growth Earnings group reads lowest at 5,385 KRW, and 20 of the 23 models stay below the price. Evidence for this calculation is medium.

Scenario range: 7,074 KRW (bear) to 9,102 KRW (bull), the price of 10,470 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 52/100 (solid quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Cho Bi reported revenue of 99.7B KRW in FY2025 versus 84.6B KRW in FY2021, a compound +4.2%/yr. Reported net income was 2.0B KRW in FY2025, compounding +1.6%/yr from FY2021.

Key figures

Market cap 54.4B KRW (≈ $40.0M) · P/S ratio 0.93 · Net margin 2.0% · Return on equity 0.1% · Return on assets (EBIT) 2.9% · Operating margin −19.1% · Revenue (TTM) 58.5B KRW · Revenue growth (YoY) −9.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

The share trades about 40% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at 10% fair-value upside, at −22%, 001550 screens richer than that median.

Fair Value models

Bear 7,074 KRW Fair Value 8,154 KRW Bull 9,102 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 6,882 KRW 9,529 KRW 13,174 KRW 78
Growth DCF 7,033 KRW 9,461 KRW 12,653 KRW 77
Owner Earnings 6,324 KRW 8,732 KRW 12,048 KRW 75
All 23 models by family
DCF Models
FCF DCF 6,882 KRW 9,529 KRW 13,174 KRW 78
Owner Earnings 6,324 KRW 8,732 KRW 12,048 KRW 75
5Y Revenue Exit 6,941 KRW 10,248 KRW 14,332 KRW 70
5Y EBITDA Exit 7,441 KRW 11,142 KRW 15,284 KRW 73
5Y P/E Exit 5,665 KRW 7,966 KRW 10,248 KRW 69
10Y Revenue Exit 6,674 KRW 9,584 KRW 13,210 KRW 65
10Y EBITDA Exit 7,165 KRW 10,176 KRW 13,892 KRW 67
10Y P/E Exit 6,078 KRW 8,072 KRW 10,286 KRW 63
Earnings-Based
Graham-Dodd 2,584 KRW 6,294 KRW 8,140 KRW 63
PEG = 1.0 1,123 KRW 1,604 KRW 2,085 KRW 55
EPV 6,710 KRW 7,661 KRW 8,481 KRW 74
Multiples
P/E Multiple 4,845 KRW 6,460 KRW 8,075 KRW 63
P/S Multiple 4,845 KRW 6,460 KRW 8,075 KRW 58
P/B Multiple 4,845 KRW 6,460 KRW 8,075 KRW 55
EV/EBIT 8,416 KRW 10,991 KRW 13,567 KRW 66
EV/EBITDA 8,777 KRW 11,472 KRW 14,168 KRW 67
EV/Revenue 7,386 KRW 10,256 KRW 13,125 KRW 54
Asset-Based
NCAV (Graham) 5,267 KRW 7,058 KRW 10,535 KRW 54
Growth DCF
Growth DCF 7,033 KRW 9,461 KRW 12,653 KRW 77
Rev-Margin DCF 6,941 KRW 10,306 KRW 13,943 KRW 71
Economic Profit
Residual Income 7,641 KRW 7,458 KRW 6,417 KRW 68
ROIC Compounder 6,710 KRW 7,661 KRW 8,481 KRW 70
Growth Earnings
Growth-Adj P/E 3,770 KRW 5,385 KRW 7,001 KRW 65

Open the full fair value analysis →

Notify me when 001550 reaches fair value

Put 001550 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 52/100

Of which business quality 50 · Market factors (momentum, volatility) 28

Profitability 32
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 37
Earnings quality: real cash, not paper profit
Fin. Strength 35
Balance sheet, leverage, solvency risk
Investment 99
Disciplined investing over empire-building
Low Volatility 53
Calm price path (market factor)
Momentum 19
Price trend over the last 3–12 months (market factor)
52W Momentum 14
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Start year 2020 (pandemic). Over 10 years: +5.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−4.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.1%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 4%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+30.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +27.7% a year for the price.

001550 screens 28% overvalued. Compare with Corteva, Inc →

Compare Cho Bi with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 180 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 52 · Above median
Fair Value upside −22% · Below median
Profitability
Return on equity (TTM) 0% · Bottom 25%
Return on assets 1% · Below median
Net margin (TTM) 0% · Bottom 25%
Operating margin (TTM) −19% · Bottom 25%
Growth and dividend
Revenue growth −10% · Bottom 25%
Balance sheet
Debt / equity 0.02× · Below median

Valuation Multiplesvs Agricultural Inputs median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)4 · sector 20
FUTURE (revenue growth)0 · sector 36
PAST (return on equity)0 · sector 24
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $80.34 $28.49 −65%
Nutrien Ltd NTR $75.13 $82.61 +10%
Qinghai Salt Lake Industry Co 000792 ¥24.87 ¥27.36 +10%
CF Industries Holdings CF $120.64 $161.00 +33%
SABIC Agri-Nutrients Company 2020 124.00 SAR 150.65 SAR +21%
Yara International ASA YAR kr 446.70 kr 659.87 +48%
Yunnan Yuntianhua Co 600096 ¥27.95 ¥50.49 +81%
The Mosaic Company MOS $24.73 $25.77 +4%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥39.75 ¥38.01 −4%
ICL Group ICL $5.40 $2.98 −45%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Cho Bi Fair Value". https://www.fairvalue-calculator.com/stock/001550

Frequently asked questions

Is Cho Bi (001550) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 8,154 KRW versus a price of 10,470 KRW, about −22% upside (overvalued).
What is the fair value of 001550?
Our model-based fair value for Cho Bi is 8,154 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 10,470 KRW.
What is the quality score of 001550?
Cho Bi has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cho Bi (001550)?
Our model-based price target is the fair value of 8,154 KRW (as of Sep 24, 2026) from 23 valuation models. Cautious scenario 7,074 KRW, optimistic scenario 9,102 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cho Bi stock forecast for 2026?
Our models put fair value at 8,154 KRW, about −22% upside versus a price of 10,470 KRW (overvalued). Cautious scenario 7,074 KRW, optimistic scenario 9,102 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cho Bi (001550)?
Cho Bi reported trailing-twelve-month revenue of about 58.5B KRW (latest available figure, as of Sep 24, 2026).
What growth is priced into Cho Bi (001550)?
For today's price to be fair in a discounted-cash-flow model, Cho Bi would have to grow free cash flow by +30.4 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 001550 use?
Our models discount Cho Bi at 8.9 %: a base by market capitalisation (nano), damped by beta 0.27, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cho Bi that is +30.4 % per year a year over ten years, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has Cho Bi (001550) delivered so far?
Over the past 5 years revenue at Cho Bi grew +6.3 % a year. The price currently implies +30.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cho Bi (001550) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Cho Bi (+30.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cho Bi (001550)?
The free-cash-flow yield on the price is 2.54 %: that much free cash flow Cho Bi produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cho Bi (001550)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cho Bi it is 8,154 KRW per share (as of Sep 24, 2026), against a price of 10,470 KRW. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Cho Bi stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 001550 trades above its calculated fair value: price 10,470 KRW, fair value 8,154 KRW, a gap of about −22% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 001550?
No. The price is what the market pays today (10,470 KRW); the fair value is what the company's own numbers justify (8,154 KRW). For Cho Bi the two are 2,316 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cho Bi worth?
The market values Cho Bi at about 54.4B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 10,470 KRW; our models calculate a fair value of 8,154 KRW per share.
What do the bullish and bearish scenarios say about 001550?
Our models span a range for Cho Bi: cautious scenario 7,074 KRW, base 8,154 KRW, optimistic 9,102 KRW per share (as of Sep 24, 2026, price 10,470 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cho Bi (001550)?
Balance-sheet figures for Cho Bi (as of Sep 24, 2026): return on equity 0.1%, debt of 0.02 per unit of equity. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is 001550 from its 52-week high?
Cho Bi trades at 10,470 KRW, about 40% below its 52-week high of 17,450 KRW and 14% above the low of 9,210 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 8,154 KRW is for.
Which stocks are comparable to Cho Bi?
From the same area (Basic Materials) we also value Corteva, Inc, Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cho Bi stock attractive at the current price?
The data as of Sep 24, 2026: price 10,470 KRW, calculated fair value 8,154 KRW (−22%), Quality Score 52/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 001550 calculated?
We run Cho Bi through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 8,154 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Cho Bi itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cho Bi (001550)?
The closing price on Sep 23, 2026 was 10,470 KRW. Our model-based fair value is 8,154 KRW, about −22% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cho Bi right now?
The price sits above even our optimistic bull case (9,102 KRW). The favourable scenario is already priced in. Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of Cho Bi

How large is the market capitalisation of Cho Bi (001550)?
The market capitalisation of Cho Bi is 54.4B KRW (≈ $40.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cho Bi (001550)?
The price-to-sales ratio of Cho Bi is 0.93 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Cho Bi (001550)?
The net margin of Cho Bi is 2.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cho Bi (001550)?
The return on equity (ROE) of Cho Bi is 0.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cho Bi (001550)?
On an EBIT basis the return on assets of Cho Bi is 2.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cho Bi (001550)?
The operating margin of Cho Bi is −19.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cho Bi (001550)?
Revenue at Cho Bi is growing −9.7% versus a year earlier (3y avg −12.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Cho Bi (001550) carry?
The net debt of Cho Bi is 38.9B KRW (fiscal year 2025, ≈ 28.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Cho Bi in the live analysis

One click puts Cho Bi on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.